GC Cell Corporation (KOSDAQ:144510)
South Korea · Delayed Price · Currency is KRW 14,810
-300 (-1.99%)
Aug 12, 2026, 2:38 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 227.06 billion as of August 11, 2026. Its market cap has decreased by -24.18% in one year.
Market Cap
227.06B
Enterprise Value
327.70B
Revenue
163.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,810.00
ChartMarket Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 227.06B, a decrease of -55.27%. That is a compound annual growth rate of -7.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 227.06B | -39.20% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 364.46B |
| Proteina | 336.57B |
| SillaJen | 315.21B |
| BINEX | 239.81B |
| HLB Therapeutics | 218.00B |
| EASY BIO,Inc. | 214.70B |
| Bioneer | 191.25B |
| JETEMA, | 169.66B |